WELLS FARGO & COMPANY/MN
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,497,589
+$566,035 QoQ
Shares Held
128,789
-18.7% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ARWR ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,497,589 | 128,789 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,931,554 | 158,398 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $10,124,938 | 152,507 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,767,304 | 80,235 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,080,308 | 68,374 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $857,910 | 67,340 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,182,256 | 62,886 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $851,368 | 43,953 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,207,779 | 46,471 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,290,773 | 45,132 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,600,837 | 52,315 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,803,532 | 104,337 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,924,381 | 110,050 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,683,152 | 105,636 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,301,116 | 155,353 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,359,749 | 162,171 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,309,947 | 150,808 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,888,530 | 193,271 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,154,318 | 213,489 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,454,412 | 215,512 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,650,399 | 225,192 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,752,556 | 252,640 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,474,630 | 266,840 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $10,157,638 | 235,895 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $11,250,129 | 260,480 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,528,975 | 226,937 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||